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Abstract
Cellular agriculture is a field of biotechnology focused on the production of animal products using cells
grown in vitro . Traditional meat production consumes vast amounts of water, arable land, and feed crops,
as well as driving deforestation, emitting large amounts of greenhouse gases, and creating large potential
reservoirs for zoonotic diseases. As the global demand for meat increases, continuing to scale up the
industry for slaughtered meat could have disastrous consequences for the environment. Growing cells in
bioreactors creates the potential to drastically decrease land requirements, feed requirements, and other
environmental impacts. For example, hindgut fermentation of feed, the main source of methane
emissions from cattle farming, can be eliminated entirely by supplying the cells with pure glucose.
This report proposes a process to produce 35 million pounds per year of a cultured ground beef product.
The process starts with a starter colony of bovine muscle satellite cells, which are proliferated,
differentiated to bovine muscle fiber, and then dewetted, mixed with plant-based fat, and extruded to the
final product. Bubble column bioreactors are used for the seed train, final proliferation, and differentiation
steps in order to adequately oxygenate large process volumes without threatening cell viability. The
process shows profitability at a price of $100 per pound of product. The plant has a return on investment
of 217%, an investor’s rate of return of 223%, and a cumulative net present value of about $2 billion over
the plant’s lifespan.
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Abstract
Cellular agriculture is a field of biotechnology focused on the production of animal products
using cells grown in vitro. Traditional meat production consumes vast amounts of water, arable
land, and feed crops, as well as driving deforestation, emitting large amounts of greenhouse
gases, and creating large potential reservoirs for zoonotic diseases. As the global demand for
meat increases, continuing to scale up the industry for slaughtered meat could have disastrous
consequences for the environment. Growing cells in bioreactors creates the potential to
drastically decrease land requirements, feed requirements, and other environmental impacts. For
example, hindgut fermentation of feed, the main source of methane emissions from cattle
farming, can be eliminated entirely by supplying the cells with pure glucose.
This report proposes a process to produce 35 million pounds per year of a cultured ground beef
product. The process starts with a starter colony of bovine muscle satellite cells, which are
proliferated, differentiated to bovine muscle fiber, and then dewetted, mixed with plant-based fat,
and extruded to the final product. Bubble column bioreactors are used for the seed train, final
proliferation, and differentiation steps in order to adequately oxygenate large process volumes
without threatening cell viability. The process shows profitability at a price of $100 per pound of
product. The plant has a return on investment of 217%, an investor’s rate of return of 223%, and
a cumulative net present value of about $2 billion over the plant’s lifespan.
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Section 1: Introduction and Objective
a. Project Motivation
Meat is the staple protein source in most humans’ diets and, given the rise in the human
population, current methods of meat production may no longer be able to scale with future
demand. The environmental impacts of increasing meat production are also potentially
devastating: livestock is responsible for 14.5% of global greenhouse gas emissions, with 44% of
those emissions being methane (Gerber et al., 2013). Globally, 77% of agricultural land is being
used for meat and dairy livestock, while only supplying 18% of calories produced (Ritchie,
2019). Beef production alone is responsible for 41% of deforestation each year (Ritchie, 2021).
The growing field of cellular agriculture, a field of biotechnology focused on the
production of animal cells in vitro, offers potential for a sustainable alternative. Growing isolated
tissue rather than an entire animal substantially reduces the resource requirements and air, soil,
and water pollution for meat production. Furthermore, industrial cultured meat production would
also decrease the chances of foodborne illnesses, and decrease antibiotic resistance in humans as
in vitro meat does not require antibiotics.
As opposed to plant-based meat alternatives, cultured meat contains real animal tissue
like muscle and fat. Therefore, with the proper structure, cultured meat products can look, feel,
and taste identical to their traditional counterparts - but without the need to raise and slaughter a
living, thinking animal. Slaughter-free, eco-friendly meat products can appeal to some
vegetarians as well as meat-eaters, converging different customer bases together.
The basic production method for cultured meat involves three steps: proliferation,
differentiation, and processing. First, a starter colony of stem cells is grown on microcarriers
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through a series of reactors of increasing size, allowing the cells to divide and proliferate. Next,
the growth medium (the nutrient broth in which the cells grow) is adjusted to induce the stem
cells to stop dividing and instead differentiate into the desired tissues. Finally, the differentiated
cells are dewetted and processed into the final product. Here, it was decided to culture beef
muscle fiber, mix it with plant-based fat, and extrude it to produce cultured ground beef.
b. Project Goals
The goal of this project is to develop a plant design for manufacturing a cultured meat
product for human consumption. Due to the lack of existing regulations on cultured meat
products in the United States, the authors have decided to focus on adhering to the standards set
forth by the United States Department of Agriculture and Food and Drug Administration
regarding slaughtered meat.
To provide a viable alternative to current slaughter meat production, the manufacturing
goal from the project statement is to produce 35 million pounds of cultured meat product per
year using an aerobic upstream process and a primarily plant-based growth medium.
c. Time Chart
The timeline for meeting set deadlines in completing the project is outlined below. In late
December and early January, the team met with project author Dr. Jeffrey Cohen and project
advisor Dr. Bomyi Lim to discuss the current literature and make early design decisions such as
product type (e.g. pork vs beef, sausage vs burger) and current technologies regarding lab-grown
meat. The month of February was used to design and produce a process flow diagram including
the upstream and downstream process units. Early March was dedicated to report writing and
delivering a presentation to the department indicating the team’s progress since the start of the
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semester. The remainder of March was used to document the utilities and raw materials needed
to meet production goals. April’s deliverables focused on economic analysis and finalizing the
report to meet the project deadline.

Figure 1.1: Objective time-chart. This image outlines the deliverables and how the team
achieved the project deadlines.
d. Project Deliverables
The project deliverables include an intermediate presentation, final written report, and
final presentation. The scope of this project involves the creation of a plant design for the
industrial manufacture of 35 million pounds of a cultured beef product with a primarily
plant-based growth medium. Bovine muscle satellite cells (BMSc) were the cell line chosen for
this project after a literature search on lab-grown meat products. The group also considered
chicken and porcine cell lines but dismissed them due to the lack of research on their growth

16
kinetics. Current research offers the most information on the proliferation and differentiation of
bovine cell lines, specifically BMSc.
With that in mind, a full process flow diagram is included to outline the many steps
required for the production process from upstream manufacturing to downstream manufacturing
and various utilities along the way. The report further details the equipment specifications and
costs associated with each of the operations to match the needs of the BMSc line. To provide an
in-depth understanding of the economics of the process, the location is specified to be in the
Midwest: Illinois. The plant location was influenced by the accessibility of required materials in
the area; namely, Illinois is one of the United States’ top producers of corn and soy (Grant,
2022), which are required in large quantities to feed the cells. The raw material costs, total
capital investment, and profitability analysis are also taken into account to recommend a product
price in order to deliver a return on investment.
Apart from the scientific and financial considerations explored in this report, there are
also environmental, ethical, and regulatory standards to be considered. Beef generally has one of
the highest environmental impacts compared to other meats and the report offers a comparison of
the costs associated with in vivo and in vitro production. The purpose of the report is to provide a
conclusive analysis of the process to take laboratory-scale production into industrial manufacture
of an in vitro cultured beef product.
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Section 2: Market Analysis
The Food and Agriculture Organization (FAO) of the United Nations projected that
annual global demand for meat would reach 455 million metric tons or 1 trillion pounds by 2050,
representing a 76% increase since 2005 (Silva, 2018). As of 2020, current global meat
production is 328 million metric tons, or 724 billion pounds per year (Shahbandeh, 2022). With
the projected future demand for meat far exceeding the current supply, an alternative production
method is critical.
Not only does the rise of cellular agriculture provide a solution to meat supply and
demand, but it also represents a new market. The cultured meat market was valued at $1.64
million in 2021, estimated to reach $2.79 billion by 2030 (Allied Analytics, 2021), thereby
indicating the robust growth that the industry is expected to undergo. In the past ten years alone,
the costs associated with producing cultured meat products have substantially decreased. For
example, the first cultured meat burger manufactured in 2013 cost $332,000 in research funds to
produce (Kelland, 2013), whereas a cultured chicken nugget cost a mere $50 to fabricate in 2019
(Shanker, 2019). Given the rapid growth of cellular agriculture exhibited in the past few years,
production costs would likely decrease as the manufacturing processes become more robust and
scaled up.
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Section 3: Competitive Analysis
As of the writing of this report, there are no cultured meat products approved for sale in
the United States. However, in 2019 the US Department of Agriculture’s Food Safety &
Inspection Service (USDA FSIS) and the Food and Drug Administration (FDA) announced an
agreement on how to jointly regulate cultured meat (US FDA, 2020). Under this joint
framework, the FDA will oversee cell proliferation and differentiation before transferring
oversight to the FSIS; the FSIS will oversee downstream processing from cell harvest to final
product packaging and labeling (USDA Press, 2021). This agreement paves the way for cultured
meat companies to seek approval to operate in the United States in the near future.
In other regions, there are several companies that are beginning to bring their products to
consumers (see Table 3.1 for a summary). The most notable, Eat Just’s GOOD Meat, has
received approval in Singapore for cultured chicken nuggets and was the first to sell a cultured
meat product to consumers in December 2020 (Gilchrist, 2021). Currently, there are no direct
competitors to this project’s specific product, cultured beef, on the market, but two of the most
prominent companies in that space are Israel-based Aleph Farms and Netherlands-based Mosa
Meat. Aleph Farms, founded in 2017, announced the world’s first cultured steak in 2018
(Ashkenazi, 2021) and in February 2022 unveiled a 65,000 m2 pilot facility they plan to use to
continue scaling up their steak production process (Aleph Farms, 2022). Mosa Meat, founded in
2016 by the researchers who demonstrated the first cultured burger in 2013, was approved in
March 2022 to allow the public to begin sampling their cultured burger in controlled settings in
the Netherlands (De Lorenzo, 2022).
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Table 3.1. Summary of notable competitors in the cultured meat space.
Company
Name

Location

Year
Founded

Main Product

Latest Progress

Eat Just

United States

2011

Chicken

Approved for sale in Singapore (Dec. 2020)

Aleph
Farms

Israel

2017

Beef Steak

65,000 m2 pilot facility (Feb. 2022)

Mosa Meat

Netherlands

2016

Beef Burgers

Approved for tastings in the Netherlands
(Mar. 2022)
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Section 4: Customer Requirements
The final product is for human consumption and therefore must comply with the
regulatory requirements for meat for human consumption set forth by the United States
Department of Agriculture (USDA) and the Food and Drug Administration (FDA). The final
product is ground beef with 80% protein content provided by bovine muscle cells and 20% fat
content from hydrogenated vegetable oil. The decision to focus on guidelines set forth by the
United States government is associated with the lack of existing regulatory standards for a
cultured beef product.
The USDA’s Food Safety and Inspection Service (FSIS) is responsible for inspecting all
meat products that are to be shipped and sold across state borders (USDA FSIS, 2016b) under
the Federal Meat Inspection Act. While many states have their own governing bodies for meat
sold within their own borders, this project focuses on a nationwide product that would fall under
the federal government’s jurisdiction. Given that the product is ground beef to be sold to a
distributor responsible for packaging and form, this product does not need to be graded
according to federal regulations.
Nevertheless, the product must still be inspected to ensure that it is sanitary, safe for
human consumption, and correctly packaged. The process outlined in this report falls under the
first subchapter of the Federal Meat Inspection Act: Inspection Requirements; Adulteration &
Misbranding, (USDA FSIS, 2016a). Due to the non-slaughter nature of a cultured beef product,
the amendments and sections that apply to this project regard sanitation and labeling of the
product alone. Sections 607-609 of the Code calls for the proper labeling, marking, and
containment of the product by which this process will abide in that an inspector will supervise
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during the day and night to guarantee adherence to sanitary guidelines (Federal Meat Inspection
Act, 1906).
Though the product is primarily cultured beef, the addition of hydrogenated vegetable oil
as a fat component requires that the product follow FDA guidelines under the Compliance Policy
Guideline Sec 565.100, FDA Jurisdiction Over Meat and Poultry Products. To prevent multiple
government agencies from re-inspecting the same product, the FDA can use their jurisdiction
under the Federal Food, Drug, and Cosmetic Act to inspect rather than the USDA’s FSIS.
However, the nature of the product indicates that the USDA will have the final say in
determining whether the product is safe for human consumption, (US Office of Regulatory
Affairs, 2018).
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Section 5: Preliminary Process synthesis
The novelty of cellular agriculture presents a challenge in that many of the existing
processes focus on lab-scale production which needs to be scaled up to meet the stated
manufacturing goals. Any existing large-scale processes are kept private as industry secrets,
thereby increasing the difficulty of the project. The team utilized current lab-scale methods in the
early upstream processes and scaled up using standard industry practices for adherent cells,
which require attaching to a surface to grow optimally. This surface was provided by
microcarriers, small beads used in cell culture in order to give cells something to adhere to while
also increasing surface area for mass and energy exchange with the cell culture medium.
Fortunately, many of the downstream processing units follow industry standards for the
processing and storage of the finished product. The challenges presented throughout the project
are highlighted below.
The first challenge in which the group was presented was to determine the type of
cultured meat product to produce. After reviewing the available research, it was noted that
cultured beef is the meat product on which most lab-scale in vitro meat projects were focused on.
Due to the availability of this data and research, the team chose to industrialize current lab-scale
technologies for cultured ground beef. Another reason for this choice is that it allows for a
thorough comparison between in vitro and in vivo methods to produce one of the most
environmentally costly meat products: beef.
The bovine muscle satellite cell (BMSc) line was decided upon as they can only be
differentiated into a limited number of tissue types, depending on the medium used for
differentiation (Williams et al., 2012), reducing the potential for non-desired tissue types in the
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final product. This process focuses on the differentiation of these satellite cells into muscle cells
to create a protein-rich cell product. In the final steps of downstream processing, hydrogenated
vegetable oil is used as a fat source to develop a protein to fat ratio of 80:20.

a. Scale-up of Lab-scale Processes to Industrial-scale
When scaling laboratory technology to industrial size process equipment, factors such as
enthalpy of growth, sterility, and separation processes become more important. While cell
growth times remain stable between the two processes, the amount of heat produced on the
industrial scale becomes much more problematic. Therefore, the addition of cooling jackets to
production bioreactors was a necessary step in preventing cell death due to overheating. The
enthalpy change associated with growth kinetics must be considered differently between the two
cases as an ice bath is not a suitable means for keeping internal process temperature consistent at
36.5℃ when reactors are hundreds of thousands of liters large. As a result of such reactor sizes,
maintaining sterility proves difficult.
If reactor temperatures rise or fall beyond the optimal growth temperatures, cell death can
complicate sterility between batches. The goal of the proliferation and differentiation phases of
the process is to keep the cells alive until the downstream dewatering step. The purpose of this
goal is to guarantee the longest possible shelf life of the product once ready for sale. Not only is
sterility important in increasing the longevity of the cultured beef, but also to satisfy the
aforementioned USDA guidelines on sanitary production. This challenge differs in production
scale from lab-scale as the majority of laboratory equipment is single-use and/or can be
disassembled for cleaning and sterilization, and therefore does not require the clean-in-place
necessary at industrial scale to prevent cross-contamination between batches.
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Another aspect that influences sterility and cell death is the oxygen uptake rate of the
cells and determining the mass transfer coefficient (kLa) for optimal oxygen transfer rate. At
insufficient dissolved oxygen concentrations, hypoxia may result in significant cell death
compromising the entire batch. At excessive oxygen concentrations, the volumetric mass transfer
ratio becomes significantly smaller thereby decreasing the efficiency of the sparge oxygen
delivery. As opposed to laboratory scale, where shaking can provide sufficient aeration, the
industrialization of these processes includes the addition of gas sparges in all bioreactors. These
considerations are taken into account and further explained in Section 7: Process Synthesis.
The determination of a fed-batch approach to meet manufacturing goals differs from
current research in that many experiments regarding cultured meat are conducted in a batch
modality. As a result of the cell requiring microcarriers to grow, it was concluded that a
continuous approach would not be optimal or even feasible. The inclusion of microcarriers and
differing requirements at the proliferation and differentiation stages would complicate a
continuous model. Therefore, a fed-batch approach would allow varying growth media
compositions to optimize growth and limit any sterility concerns between batches. Increased
cleaning and clear delineations between batches would minimize the sterility concerns and
maximize outputs in line with current regulations.
b. Plant-Based Growth Media
This project also involved developing a primarily plant-based growth medium. However,
traditional growth media require a significant amount of fetal bovine serum (FBS), a byproduct
of cattle slaughter. FBS contains nutrients, hormones, and other growth factors critical for cell
growth, mimicking the complex native environment surrounding mammalian cells (van der Valk
et al., 2010). BMSc proliferation medium typically contains up to 20% FBS (Khasawneh et al.,
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2019), while differentiation medium uses 2% FBS or similar animal products such as horse
serum (Xu et al., 2018). Reducing the use of FBS provides us with an opportunity to differentiate
the product from prior work.
The base for the plant-based medium was based on cell glucose and glutamine
requirements as cell energy and growth requirements are based on these metrics. To obtain these
requirements, a cell culture medium containing both corn grain hydrolysate and soybean
hydrolysate was used to match the glucose and amino acid profiles needed for optimal growth.
Not only are these components necessary for cellular respiration, but also for the
generation of more cells. As a result, the hydrocarbon source for glucose chosen was corn grain
hydrolysate due to its high reducing sugar content, (Huang et al., 2017). The amino acid source
for glutamine, which proves to be the cells’ limiting amino acid (Quang & Zakardas, 1989), is
soybean hydrolysate due to its high protein content. Combining the two plant hydrolysates
satisfies upstream plant-based growth media requirements.
The use of FBS complicates the goal of an entirely slaughter-free meat alternative.
However, this process sought to minimize the use of FBS wherever possible. Based on recent
research, the FBS requirement of this proliferation medium can be reduced to 10% by weight,
and it was determined that FBS could be eliminated entirely from the differentiation medium
(Will et al., 2015). While additives differ between proliferation and differentiation media, the
plant-based growth media primarily featured the corn grain and soybean hydrolysates as the
main nutrient source for the cells.
Initially, the team planned to introduce a hammer mill and enzymatic hydrolysis unit for
both the corn grain and soybean to minimize the costs associated with the raw materials for this
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plant. The location of the plant in Illinois, where corn grain and soybean production are among
the highest in the nation, indicated that allocating for hydrolysates would lower the total capital
investment required. However, ultimately allocating on-site processing of raw corn and soy
proved beyond the scope of the project.
c. Separation of Media and Microcarriers from Cell Slurry
Due to the adherent nature of the BMSc line, the use of microcarriers are critical in
meeting the optimal growth density in the bioreactors to meet manufacturing goals. Current
research shows that Cytodex I microcarriers are the best option for BMSc growth (Luining,
2015). Cytodex I microcarriers are composed of dextran, which provides a nontoxic supportive
structure for the cells to proliferate and differentiate on during the upstream process. However,
its inclusion in the final product would compromise the taste and texture of the cultured beef
product. Therefore, its exclusion in the downstream processing steps is necessary. This section
discusses the various methods explored in research to remove the cells from the beads and how
this process intends on separating them.
Trypsin and EDTA are two industry-known chemicals that can remove cells from the
surface of a microcarrier. The costs associated with trypsin, an enzyme known to dislodge
adherent cells from the surface of the microcarriers, were far too high to consider and would not
solve the problem of ridding the cell solution from the microcarrier waste. Also, trypsin may
increase cell loss on the surface of a microcarrier as it is quite ineffective when compared to
EDTA (Rourou et al., 2013). While adding EDTA to a cell slurry decreased cell loss, the
concentration of EDTA increases cell death as EDTA is a known cytotoxic chemical (Luining,
2015).
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Microcarriers also complicate the downstream separation steps. Not only would the
downstream processing units need to include a solid-liquid separation device, but also a
solid-solid separation unit. Solid-solid separation devices are much more difficult to design,
especially if the desired solid is significantly smaller than the solid it is to be separated from. In
this case, a simple deadend filtration device would not be sufficient due to the small size
difference between the cells and the microcarriers. Therefore, additional separation units would
be necessary to achieve the desired product. The affinity of the cells to the microcarriers further
complicates the issue.
However, there is an alternative to releasing the cells from the microcarriers: dissolving
the microcarrier beads entirely. Dextranase is known to be capable of dissolving dextran
microcarriers while preserving cell viability (Lindskog et al., 1987), and was thus selected as the
dissolving agent. Although dissolving the microcarriers meant that they could not be recycled for
future batches, it minimized cell losses as there would be no surface for the cells to re-adhere to
and removed the problem of having to design a solid-solid separation device. By introducing
dextranase to break down the microcarrier before the solid-liquid separation device, the
assumption can be made that none of the dextran microcarriers would remain to be removed in
the vacuum rotary drum to separate the waste metabolites and unspent media from the cell slurry.
As a result, a solid-solid separation device would no longer be required. Note that it may be
possible to improve the economics of this project if an effective solid-solid separation device
were to be implemented as it would allow for the recycling of beads and reduce raw materials.
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Section 6: Process Flow Diagram and Material Balance
a. Process Flow Diagram

Figure 6.1. Process flow diagram. The upstream and downstream processes for cultured beef. Stream
numbers are included in Section 9.
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b. Material Balances
The material balances for a fed-batch system as proposed by this project are outlined in
the following tables. The fed-batch system proposed by this process utilizes two important
features of a batch and continuous process. The charge requirements are added to the bioreactor
at the start of each batch. The continuous feeds are added throughout the process time that each
batch spends in each bioreactor. As a result, the following tables are designated according to
bioreactor charge requirements, continuous feeds throughout the process, and the overall annual
requirement of each raw material to produce 35 million pounds of ground beef product per year.
Table 6.1 indicates the amount of each substance needed to attain an optimal growth
density of 60 million cells per mL and maintain this density throughout the differentiation stage
of the process. The bioreactors are named according to the process flow diagram shown
previously, but there is a distinction between final proliferation reactor (FPR) 1 at full harvest
and half harvest. This difference denotes when the contents of the entire reactor are sent to
differentiation reactor (DR) 1 and when only half of its contents are sent to DR 2, DR 3, or DR 4
as they operate at half the capacity of DR 1. While the exact same proliferation reactor is used,
half of it is harvested three times, each time allowing the contents to double again between
harvests, until the fourth and final harvest takes the full contents of the FPR and sends it to DR 1.
The purpose of the multiple harvests is to maximize the amount of product that can be produced
from one batch, as proliferation is extremely time-intensive, taking 31 days from the beginning
of the seed train to the first half harvest.
Note that insulin, linoleic acid, and dexamethasone are not included in the proliferation
stages of the process. The addition of insulin, linoleic acid, and dexamethasone, along with the
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cessation of adding FBS, induces the stem cells to begin differentiating (Will et al., 2015). This
serum-free differentiation medium was taken from a review in which various serum-free media
are explored and compared to the performance of cells in FBS-containing media (Will et al.,
2015). In addition, Cytodex I microcarriers are not included in the differentiation stages, as cell
division halts during differentiation, and thus additional microcarriers no longer need to be
added.
Table 6.1: Batch bioreactor charge requirements for cell proliferation/differentiation
Soybean
Corn Grain
Hydrolysate Hydrolysate

[lbs/batch] [lbs/batch]

FBS
Insulin
[lbs/batch] [lbs/batch]

Linoleic
Dexamethasone Cytodex 1
Acid
[lbs/batch] [lbs/batch]
[lbs/batch]

SR 1

0.002

0.001

0.0004

-

-

-

1.6

SR 2

0.05

0.03

0.009

-

-

-

40

SR 3

0.37

0.23

0.07

-

-

-

700

FPR 1

44

28

8.0

-

-

-

88,000

44

14

6.5

-

-

-

44,000

DR 1

44

28

-

0.22

0.47

0.19

-

DR 2

22

14

-

0.11

0.24

0.09

-

DR 3

22

14

-

0.11

0.24

0.09

-

DR 4

22

14

-

0.11

0.24

0.09

-

(Full Harvest)

FPR 1
(Half Harvest)

Batch requirements differ from the continuous feed supplied to the reactors in that it
provides the necessary reactor initial concentrations to induce an optimal growth environment.
Therefore, Table 6.2 summarizes the necessary additions that need to be made to ensure that this
growth environment is kept stable. The important factors include glucose, glutamine, and water
such that optimal growth can occur. Only process water, soybean hydrolysate, and corn grain
hydrolysate are added continuously. These are the three main components that the cells need to
undergo cellular respiration and grow under specified conditions. As a result of the generous
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charge amounts of growth regulators such as FBS and Cytodex I microcarriers, and
differentiation inducers such as insulin, linoleic acid, and dexamethasone, the cells grow and
differentiate in their bioreactors in the presence of all the necessary components. While it would
be possible to charge the vessels with all necessary media from the start, it would not allow for
control of the optimal growth density. By not controlling the chosen cell density, the cells may
overpopulate the bioreactors leading to possible cell exhaustion and death.
Table 6.2: Continuous feed bioreactor requirements for cell proliferation/differentiation
Process Water
[lbs/hr]

Soybean Hydrolysate
[lbs/hr]

Corn Grain Hydrolysate

SR 1

0.003

0.004

0.003

SR 2

0.07

0.10

0.07

SR 3

0.54

1.98

1.3

FPR 1

39

150

99

20

76

50

DR 1

140

52

4

DR 2

69

26

2

DR 3

69

26

2

DR 4

69

26

2

(Full Harvest)

FPR 1
(Half Harvest)

[lbs/hr]

A fed-batch system in which components are added to each bioreactor for varying
amounts of time results in a complex equation for determining the yearly requirements for each
material in the production of a lab-grown meat product. Table 6.3 briefly summarizes these
calculations in which each requirement is determined. The charge amount is first added to the
product of the material flow rate and time spent in the reactor per batch. Then, this sum is
multiplied by the number of batches produced per year. The major components of the material
balance are the process and cooling water, soybean hydrolysate, corn grain hydrolysate,
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microcarriers, air, and cooling water as their requirements are well into the millions of pounds
per year. Also, the starter cells, FBS, linoleic acid, insulin, and dexamethasone are necessary for
adequate growth and differentiation as previously noted.
Table 6.3: Yearly requirements for cell proliferation/differentiation
Component

Annual Requirement

Units

Process Water

6.4

million lbs

Starter Cells

8.3

lbs

Soybean Hydrolysate

110

million lbs

Corn Grain Hydrolysate

75

million lbs

Microcarriers

8.6

million lbs

Air

940

million lbs

FBS

1.1

thousand lbs

Linoleic Acid

46

lbs

Insulin

21

lbs

Dexamethasone

18

lbs

While Table 6.3 outlines the total yearly requirement of the upstream processes alone,
Table 6.4 focuses on the total annual requirements for all raw materials and cooling water
utilities that enter and exit the overall process. The necessary additions here include the amount
of dextranase, hydrogenated vegetable oil, and cooling water to produce 35 million pounds of
cultured beef product.
The amount of process water added to the bioreactors is less than the amount lost as a
result of the supernatant purge of 10% to prevent ammonia produced during growth and
differentiation from accumulating in the system. This idea continues for any of the added growth
supplements such as soybean and corn grain hydrolysates, FBS, linoleic acids, insulin, and
dexamethasone. The evaporated process water is included in the annual waste leaving in the air
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stream as it results from the dry air traveling through the bioreactors and becoming saturated.
The cooling process also evaporates water in the cooling tower and chiller which are also
included in the exiting air for the process.
Due to the use of the hydrolysates in energy production and cell mass production, there is
no clear way to distinguish how the cells are using them thereby resulting in a whole-process
mass balance that does not close. Using these hydrolysates, the process is able to grow 28 million
pounds of cells from 8.3 pounds of starter BMSc and supplement it with 7 million pounds of
hydrogenated vegetable oil to achieve the desired fat to protein ratio. It should also be noted that
the microcarriers and dextranase enter and leave the process in the same amount as they are tools
used to achieve growth and therefore, not part of the final product. As a result, 35 million pounds
of an in vitro beef product are formed per year.
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Table 6.4: Yearly requirements for overall process
Component

Annual Intake

Annual Waste

Units

Process Water

6.4

9.1

million lbs

Starter Cells

8.3

-

lbs

Soybean Hydrolysate

110

11

million lbs

Corn Grain Hydrolysate

75

7.5

million lbs

Microcarriers

8.6

8.6

million lbs

94
72
22
-

140
72
9.6
17
35

million lbs
million lbs
million lbs
million lbs
million lbs

FBS

1.1

0.11

thousand lbs

Linoleic Acid

46

4.6

lbs

Insulin

21

4.6

lbs

Dexamethasone

18

1.8

lbs

Dextranase

8.6

8.6

million lbs

Hydrogenated Vegetable Oil

7

-

million lbs

Cooling Water

29

-

million lbs

Cultured Beef Product

-

35

million lbs

Air
Nitrogen
Oxygen
Carbon Dioxide
Water Vapor

c. Timeline of Key Steps in the Process and Batch Scheduling
The biggest obstacle in batch scheduling was in ensuring efficient usage of the
bioreactors. In order to meet the production goal of 35 million pounds per year of the final
product, 28 million pounds per year of bovine muscle cells must be produced. With two final
proliferation reactors, each with a working volume of 225 m3 and harvested 4 times (see Section
7 for more detail), each batch produces approximately 739,000 pounds of cells; the process is
able to produce about 39 batches per year, for 28.6 million pounds of cells produced (thus
leaving 2% excess in case of quality control issues).
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In order to meet the required number of batches, the seed and final proliferation
bioreactors run concurrently. The three seed train bioreactors are run such that the first step takes
the longest (7.14 days), followed by the second (7.08 days), and then the third (6.35 days). This
ensures that seed train steps do not finish earlier than those that come after them; while excess
downtime is undesirable, it is vital to keep cells moving between reactors, where they have
adequate oxygen and nutrients, rather than creating a need for storage that may compromise cell
viability.
The slowest step by far is the initial growth in the final proliferation reactors, at 10.5
days. While the length of time is undesirable in terms of batch efficiency, the delay does allow us
to have both of the final proliferation reactors share the same set of seed and differentiation
reactors. Offsetting the start time of each final proliferation reactor by approximately 8 days
allows for this reduction in total bioreactors needed, as well as staggers the timing for when cells
arrive at downstream processing. See Figure 6.1 for a Gantt chart demonstrating the full
schedule.
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Figure 6.2. Bioreactor Gantt chart. For the final proliferation reactors, the unlabeled boxes
following each 10.5-day proliferation indicate the subsequent 3 doublings as the final
proliferation reactors are harvested and the cells sent to differentiation. The gaps between time
blocks represent cleaning (see “Clean-in-Place” in Section 7) and other routine maintenance.
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Section 7: Process Synthesis

a. Process Summary
The cultured meat process can be broadly divided into two categories: upstream and
downstream processing. The upstream component of the manufacturing plant focuses on the
cultivation of the cells to be used as the protein component whereas the downstream component
involves the dewatering, mixing, extrusion, and storage of the finished product.
However, each of the process units involved in the entire manufacturing process must
also be maintained under certain conditions and cleaned thoroughly. Due to the heat generation
associated with cell growth, an intricate cooling system is needed for the process to maintain
ideal growth conditions. As previously mentioned, the industrialization of a laboratory process
brings about concerns of sterility, necessitating the inclusion of a clean-in-place (CIP) procedure
for all process units which come into contact with the cell product.
The upstream process, oxygen transfer, cooling jacket network, downstream process, and
clean-in-place process are outlined in the following subsections.
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b. Upstream Process

Figure 7.1. PFD: upstream process units. Upstream process units and the associated streams
for proliferation and differentiation. The network of sterile air supplies is also included.
Upstream processing refers to the proliferation and differentiation of the cells, producing
a mixture of growth medium and cells attached to microcarriers that is sent to downstream
processing. For this process, bovine muscle satellite cells (BMSc) were used due to a greater
amount of information available about them in the literature. This cell line is adherent, meaning
it must be grown attached to a solid substrate; Cytodex 1 was selected, small dextran beads that
have been shown to best encourage BMSc growth (Luining, 2015). Following 31 days of
proliferation (see Figure 6.1), the BMSc must then be differentiated to muscle fiber final product
formation. This step is accomplished by serum starvation (the depletion of nutrients from fetal
bovine serum that occurs as the cells divide) and the addition of small concentrations of
dexamethasone, linoleic acid, and insulin (Will et al., 2015). After 72 hours (Will et al., 2015),
the BMS cells will have finished differentiating to muscle fiber and are ready to be sent to
downstream processing.
For the bioreactors, bubble columns are chosen rather than the more traditional stirred
tanks currently used in most industrial cell culture. In its simplest form, a bubble column reactor
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consists of a tall, thin cylinder with a gas sparger on the bottom and a vent on top. Gas bubbles
traveling up from the sparger keep the medium circulating and provide oxygen to the entire tank.
This reactor type was chosen in order to adequately oxygenate the largest reactors; mammalian
cells have a relatively large oxygen requirement as opposed to the bacteria and yeast primarily
grown in fermenters of this size scale. If a stirred tank had been chosen, the amount of stirring
required to uniformly oxygenate the cell growth medium would have placed the cells at risk of
injury or death from shear stress. Bubble column reactors also have the advantage of being
relatively simple to design and build. With the number of bioreactors required for the plant, this
simplicity helps us save on construction costs and reduces possible points of failure in the design
(eg, a mechanical agitator).
Due to the large size of the final proliferation reactors, 300 m3, a three-step seed train is
required in order to expand the starting cells to a concentration high enough to inoculate the
largest reactors. The first step, inoculating the first seed reactor, begins with an allocated, on-site
cell culture lab. It is assumed that there is steady access to high volumes of concentrated, frozen
cell starter such that each batch begins with 150 mL of starter at a concentration of 65 million
cells/mL, as described in a recent article in the Journal of Chemical Technology &
Biotechnology (Wong et al., 2021). The full seed train consists of a series of 3 seed reactors of
0.01, 0.33, and 2.49 m3 volumes, leading up to the cells being sent to one of two final
proliferation reactors of 300 m3 volume.
Each final proliferation reactor is harvested four times - thrice taking half the total culture
volume before allowing the cells to double again, and for the fourth and final harvest draining
the reactor entirely, in a method adapted from Guan et al. (2021). Each harvest is sent to a
differentiation reactor, so that four total are required: three of 150 m3, and one of 300 m3 volume.
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Due to the slow doubling time of the cell line, 36.6 hours (Simsa et al, 2019), the two final
proliferation reactors can be scheduled offset from one another such that the same set of seed and
differentiation reactors can be used for both (see Figure 6.1 for a bioreactor scheduling chart).

c. Oxygen Transfer

Figure 7.2. PFD: sterile air supply. Sterile Air Supply for Aerobic Bioreaction.
The upstream process includes aerobic bioreaction which uses oxygen to convert sugar
molecules to hydrocarbons for cell growth. To maintain proper growth conditions, a minimum
amount of oxygen should be present depending on the cell population in the reactor (i.e. more
oxygen is required at higher cell density). The oxygen requirement also depends on the oxygen
transfer rate (OTR) and the oxygen uptake rate (OUR). OTR refers to the absorption of oxygen
from gas bubbles to liquid while OUR is defined as the consumption of oxygen from liquid to
the cell. The OTR that is supplied by the sparger gas must equal the OUR at a steady-state to
maintain a dissolved concentration of oxygen in the liquid. A key concept to consider is the
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liquid boundary layer formed around the air bubbles which limits the OTR into the bioreactor
media. If oxygen is not properly transferred to the media from the air, it can not be consumed by
the cells as needed so it is crucial to obtain a mass transfer coefficient (kLa) for a given air
supply. It is also important to determine the pressure difference between dissolved oxygen in air
and media which acts as a driving force for OTR. This process uses a 10% dissolved oxygen
setpoint and a solubility of 0.03 grams of oxygen per kg of water (Engineering Toolbox, 2008) to
create an OTR driving force. As shown in Figure 7.2, the process is set to supply sterile air with
21% saturated oxygen to all the bioreactors. However, the flow rate of air supplied to the reactors
vary depending on the oxygen demand which is determined by a combination of equations
discussed in Appendix C.
To summarize the method, the specific OUR of mammalian cells, 0.20 pmol O2/cell/hr
(Goudar et al., 2011), and the peak viable cell density, 60 million cells/mL (Mizukami et al.,
2013), in each bioreactor is used to obtain the OUR (mmol O2/L/hr). Equating OUR to OTR and
using Fick’s first law of diffusion, the kLa requirement is determined. Then, a correlation
between kLa and gas superficial velocity in a bubble column reactor is used to obtain the sparge
gas rate that would meet the oxygen demand (Zedníková et al., 2018).
The gas bubbles need to overcome the pressure difference to reach the top of the reactor
with the help of compressors. Three compressors are used to pressurize the air for three different
supply networks. The first compressor (Comp 1) supplies air to the seed train reactors (SR1,
SR2, and SR3). Note that streams S33’ and S35’ include restriction orifices to reduce the
pressure since sparge gas rates for SR1 and SR2 are significantly lower than SR3 (see Table 9.3).
The second compressor (Comp 2) supplies air to both the final proliferation reactors (FPR 1, 2)
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and the full-sized differentiation reactor (DR1). Lastly, the third compressor (Comp 3) supplies
sterile air to the three half-sized differentiation reactors (DR 2, 3, 4).
During the aerobic bioreaction, carbon dioxide is created as a byproduct in a 1:1 mole
ratio with oxygen. Therefore, generated carbon dioxide, unreacted inert nitrogen, and the
remaining oxygen leave the reactor through the vent as depicted in Figure 7.2.

d. Cooling Jacket Network

Figure 7.3. Cooling Tower and Chiller Network. The diagram includes streams supplying
chilled water at 22℃ (blue) to all the bioreactors and warm water at 26.5℃ (red) back to the
chiller.
Throughout the entire proliferation and differentiation process, metabolic activities in the
bubble column reactors generate heat that, left unchecked, will hinder cell growth and viability
(Guan & Kemp, 1999). It is crucial to remove the additional heat generated from cell growth and
maintain the content inside the reactors at a constant temperature of 36.5℃ to keep the cells
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viable (“Cell Culture Environment,” n.d.). To do so, a cooling tower is installed onsite to supply
cold water to all the bioreactors through annular cooling jackets. Heat transfer is typically more
efficient in mechanically agitated reactors due to a thinner boundary layer on the reactor surface
as a result of higher process fluid velocity (Mahir et al., 2021). However, the optimal cell growth
condition for this process demands the use of bubble column reactors which have lower heat
transfer.
The addition of cooling jackets around each reactor will help the heat transfer process by
introducing a temperature difference. The annular cooling vessels will be made up of 304
stainless steel, which has a thermal conductivity of 16.2 W/m*K (Azo Materials, 2005). The
relatively high thermal conductivity and proper jacket thickness will provide sufficient surface
area for proper heat transfer. A thorough energy balance on the cooling jacket is further
discussed in Section 9.
Figure 7.3 shows the overall cooling jacket network for the plant. Depicted in blue lines,
chilled water at 22℃ is supplied to each bioreactor. The cooling jackets remain in contact with
the walls of each reactor, allowing heat transfer to occur from process volume to the jacket. The
heat generated from cell growth is transferred to the cooling water, raising its temperature to
26.5℃. The red lines depict the warm water that carries the generated heat from the bioreactors
back to the chiller.
For most of the year, a cooling tower alone is adequate to provide cooling water for the
plant. However, the temperature of Illinois in the summer necessitates a chiller onsite. Over the
last decade, the highest temperature experienced in Illinois ranged from 34℃ to 41℃, which is
significantly higher than the cooling water temperature that is required for the process. A chiller
can take the water from the cooling tower and bring it down to the desired temperature before
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reaching the bioreactor cooling jackets. It should be noted that the cooling jacket network may be
modified to include heat exchangers that can heat the water in winter if necessary.

e. Downstream Process

Figure 7.4. PFD: downstream process units. Downstream process units and their associated waste and
feed streams which includes the product of the upstream process units and follows the process through to
the production of the final product: ground beef.

Downstream processing refers to the separation, dewatering, and packaging steps of
cultured meat production. Following the differentiation bioreactors, the first step is a disk stack
centrifuge to dewater and remove the bulk of the liquid medium resulting in a concentrated cell
slurry containing microcarriers. A disk stack centrifuge was chosen as the ideal separation unit in
that it allowed for a sufficient amount of growth media to be removed. It also clarified the media
such that it could be sterilized and reused for subsequent batches so long that sufficient nutrients
were added.
Next, the cell suspension enters a stirred-tank reactor (STR) to allow for the addition of
dextranase. This step is required to dissolve the microcarriers and release the adherent cells for
further cell separation from the suspension. The STR plays an important role in the dissolution of
the microcarriers as it allows for the dextranase to homogenize within the solution and minimize

45
any gradients that may occur. This homogenization is critical to reducing the amount of
dextranase needed to disintegrate all microcarriers present in the cell mixture.
Dextranase is an expensive enzyme whose function is to dissolve the dextran beads
without harming the cells. The decision to place the dewatering step before the dissolution of the
microcarriers stems from this cost. To be effective in dissolving the dextran beads, the amount of
dextran added needs to be in a 1:1 ratio with the weight of microcarriers. Dewatering the slurry
before its addition was necessary to ensure that the water content of the exit stream leaving the
differentiation reactors was limited. Therefore, less dextranase would need to be added to the
stirred-tank reactor that followed. The stirred tank helps to homogenize the mixture of cells,
microcarriers, and dextranase to fully dissolve the dextran beads and dislodge the cells thereby
solving two problems at once.
The final separation step is a rotary drum vacuum dryer with minimized heat to prevent
cell death and produce a cake-like consistency of cells. The inclusion of this step is to remove
any excess media and process water to ensure a texture of the product that is analogous to
slaughter meat. The specification of the rotary drum to be a vacuum is to physically separate any
remaining liquid from the cell product without the potential for shearing the cells. This
specification also prevents cell death as a result of excessive temperatures common to other types
of drum dryers. As a result of this step, the cells are now a dry, dense protein.
Maintaining sterility and cleanliness according to FDA and USDA guidelines, all
successive steps in the downstream process are completed in a cold room to prevent spoilage and
prepare the product for sale and transport. While the meat can be stored at 0℉ for three to four
months, the cold room is kept at a temperature of 10℉. This temperature would be sufficient to
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finish processing and store the product for 3 days onsite. This decision would allow distributers
to determine how to package and market the product according to their own standards.
To prepare the final product, the cells are mixed with hydrogenated vegetable oil to
achieve an 80% protein to 20% fat content by weight. To achieve the desired ratio, hydrogenated
vegetable oil is fed to the mixer in a 1:4 ratio to cell product following its exit from the rotary
drum vacuum dryer. As a result, a total of 7 million pounds of hydrogenated vegetable oil is
added to the 28 million pounds of cells produced to achieve a total mass product for sale of 35
million pounds. The mixture is given a ground beef consistency in a twin shell tumbler to ensure
that the product is homogenous.
Following the mixer, the aggregate feeds into three extruders operating in parallel to one
another. The inclusion of six screw extruders to the process diagram allows for downstream
processing while the others are being cleaned between batches.
Finally, the product is stored in two identical storage vessels in which each will contain a
three-day supply of product due to the meat product’s relatively short shelf life. A three-day
storage supply of product is optimal as each batch of cells are produced three days within one
another as a result of the batch scheduling system described in Section 6.

f. Clean-In-Place (CIP)
In order to maintain sterility, each process unit that touches the product undergoes a
clean-in-place (CIP) cycle following each batch. For all units, the CIP cycle begins with a
greywater wash, followed by a 2% NaOH caustic wash, and finally a virgin hot water wash, as
advised by the industrial consultants. 100% of the virgin hot water is reused as greywater, while
90% of the caustic wash is reused for the next batch. The remaining 10% of the used caustic
wash is neutralized using sulfuric acid before disposal.
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The final step is sterilization. For the seed, proliferation, differentiation, and stirred tank
reactors, sterilization is accomplished using 15 psig saturated steam, bringing the interior surface
to 121°C for 15 minutes. For the remaining downstream process units - the rotary drum dryer,
centrifuges, extruders, and storage tanks - sterilization is accomplished using a 0.2% peracetic
acid (PAA) solution. For each piece of equipment, the flow rate of cleaning liquid and cycle time
for each cleaner was determined using the specifications for commercially available CIP
equipment (Alfa Laval, n.d.). A full table for the amounts of steam, hot water, and chemicals
required is provided in Appendix D.
To mix the cleaning chemicals, NaOH is purchased as dry powder and mixed with pure
water at a ratio of 2 grams NaOH to 100 grams of water. PAA is purchased as a 15% solution and
diluted with pure water to form a 0.2% solution.
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Section 8a: Equipment List and Unit Descriptions

a. Seed Reactors (SR)
The seed train system serves to proliferate a small number of starter cells to a number
sufficient to inoculate the 300 m3 final proliferation reactors. Each seed reactor (SR) is
constructed with 304 stainless steel with an attached cooling jacket to counter the enthalpy
associated with growing the cells. SR 1 serves to proliferate 9.75 billion cells to 250 billion cells
in a 0.013 m3 bubble column reactor within 7.14 days. SR 2 grows this amount of cells to 6.25
trillion cells in a larger bubble column with a volume of 0.33 m3 in 7.08 days. Finally, SR 3
achieves a final cell count of 112 trillion cells within 6.4 days in a 2.5 m3 bubble column reactor.
After achieving the desired cell concentration of 60 million cells per mL, the cells move on to the
final proliferation reactors.

b. Final Proliferation Reactors (FPR)
The two final proliferation reactors act on an offset parallel schedule, fed by the same set
of 3 seed reactors (see Figure 6.1 for a Gantt chart). These reactors are also identical in size and
function in that they are both 300 m3 volume bubble column 304 stainless steel reactors and are
equipped with a cooling jacket for the reasons aforementioned. 304 stainless steel was chosen on
the advice of the industrial consultants in order to balance bioreactor manufacturing costs with
the ability to maintain a sterile cell growth environment. The proliferation reactors are intended
to grow the cells to a peak viable cell density (VCD) of 60 million cells per mL and achieve a
final cell count of 112 trillion cells. Upon reaching peak VCD, half of the contents of the reactor
are sent to a half-size differentiation reactor (DR) before the remaining contents are allowed to
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double. This is repeated until 3 half-size DRs have been filled and the FPR is filled a final time
before being sent to a full-size DR to complete the upstream process.

c. Differentiation Reactors (DR)
There are two sizes of bubble column reactors used for optimizing the differentiation
process. All four of the differentiation reactors are built using 304 stainless steel and a cooling
jacket to absorb any heat released by the cells during respiration. DR 1 is the largest bioreactor at
300 m3 for the final harvest of cells produced in the full proliferation reactors. DR 2, DR 3, and
DR 4 are equivalent in size at 150 m3 and are designed to differentiate only half of the contents
of the final proliferation reactors.

d. Compressors (Comp)
Though there are only three compressors responsible for supplying air to all nine reactors
at once, the compressors each supply air to 3 reactors depending on the reactor sizes. The three
seed reactors receive their gas sparge from the air compressed by Comp 1. As a result, the work
required is a mere 1.9 horsepower in comparison to Comp 2 and Comp 3. Comp 2 supplies air to
all of the full-sized reactors (FPR 1, FPR 2, and DR 1) resulting in a network requirement of 660
horsepower to deliver the air at the required pressure needed to overcome the pressure within
each column. Comp 3 supplies air to the remaining half-sized differentiation reactors requiring a
total input of 330 horsepower.

e. Cooling Tower and Chiller
The addition of the cooling tower in the process flow sheet allows us to reuse the cooling
water being supplied to the jackets insulating each of the reactors. The inlet temperature of the
water entering the cooling jackets is 22.0℃ and returns to the tower at 26.5℃ to be cooled to
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22.0℃ once again. Through the process of evaporative cooling in the tower, the utility water
attains the desired temperature and only a fraction of additional cooling is purchased.
Due to the low ambient air temperatures in Illinois year-round, it was determined that a
chiller would only need to be in use during the summer months of June, July, and August to
achieve the desired temperature in the cooling water exiting the tower.

f. Pumps (P)
Pumps are required to circulate water in the bioreactor cooling jacket network. Six
cast-iron centrifugal pumps with a vertical split case and a flow rate range of 50-3500 gallons per
minute are used. Pumps P-101, P-105, and P-106 supply warm water at 26.5℃ and a pressure
drop of 2 psig to the cooling tower, chiller, and chiller respectively. Pump P-102 supplies cold
water to the chiller at 22℃ with a pressure drop of 19 psig. P-103 and P-104 supply cold water at
22℃ to full-sized reactors at a pressure drop of 17 psig and to the half-sized reactors at a
pressure drop of 13 psig, respectively.

g. Disc Stack Centrifuges (DSC)
Two identical disc stack centrifuges operate in parallel to one another. When one is in
operation, the other is set to be sanitized between batches such that the cell product is produced
as continuously as possible. These centrifuges are designed in 304 stainless steel to allow for
adequate cleaning in accordance with the clean-in-place procedure. Its 250 m3 size allows for the
separation of the solid and liquid phases of the 225 m3 entering from the upstream process.
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h. Stirred Tank Reactor (STR)
The 304 stainless steel stirred tank reactor operates to evenly distribute the added
dextranase to the process and ensure that no dextran microcarriers remain in the final product.
Due to the decreased volume of the cell precipitate coming out of the DSC, the STR is only a
fraction of the initial volume of cell slurry entering the downstream process at 75 m3. This
reactor also has a cooling jacket to ensure that the cells are provided adequate cooling and
prevent cell death and resulting contamination. Clean-in-place and steam sterilization procedures
are maintained between batches.

i. Vacuum Rotary Drum Dryer (Rotary Drum)
The vacuum rotary drum dryer serves to dewater the cell slurry and form a cake-like
consistency with the cells using a pressure difference. The dryer operates at 36.5℃ and 0 psia to
achieve the vacuum effect. The cells will adhere to the drum and excess water will be removed
during its rotation to be later mixed with the hydrogenated vegetable oil and extruded. The dryer
has an effective area of 4.65 m2 and is constructed using 304 stainless steel such that cleaning
procedures can be performed.

j. Mixer
The mixer has a volume of 5.66 m3 and is constructed of 304 stainless steel to be cleaned
and sterilized between batch scheduling. It propels a final product into the extruders with a
formulation of 80% cell concentrate and 20% hydrogenated vegetable oil. The cake-like
consistency that exits the rotary drum is now completed with the oil to give a texture akin to
traditional ground beef.
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k. Screw Extruders (Ext)
The six identical screw extruders are included for completeness, but only three are in
operation at a time. This design is such that the three extruders out of operation can be cleaned
and sterilized while the others are extruding product to ensure continuous production. They are
designed to extrude 4,000 lb/hr and operate in the cold room at 10℉ and atmospheric pressure.

l. Storage Tanks
Two storage tanks, equal in size, material, and construction, are used to contain the
product in its final form for 3 days in the cold room. As a result, they are operating at 10℉ and
atmospheric pressure. The identical vessels are 416 m3 and composed of 304 stainless steel and
follow the clean-in-place procedure outlined in Section 7.
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Section 8b: Equipment Specification Sheets

a. Seed Reactors
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b. Final Proliferation Reactors
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c. Differentiation Reactors
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d. Compressors
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e. Cooling Tower and Chiller
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f. Pumps
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61

62
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g. Disc Stack Centrifuges
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h. Stirred Tank Reactor
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i. Vacuum Rotary Drum
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j. Mixer

67
k. Screw Extruders

l. Storage Tanks
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Section 9: Energy Balance and Utility Requirement

a. Cooling Water and Chilling
To maintain the bioreactor process temperature at 36.5℃, chilled water at 22℃ is
circulated through the cooling jackets around each bioreactor at varying flow rates depending on
the reactor size. The temperature difference between the jacket and the reactor content drives the
rate of heat transfer, while the flow rate controls the amount of heat that is transferred.
The specific heat of bioreaction for CHO cells was used to model the enthalpy of cell
growth for bovine muscle satellite cells (BMSc). According to research on CHO cell growth, a
comparison between consumption of glucose and glutamine with respect to oxygen uptake rate
provides a heat flux range of 20 to 25 picoWatts per cell (Guan & Kemp, 1999). A smaller heat
flux resulted in better metabolic activities which led to the selection of 20 picoWatts/cell as the
specific heat of bioreaction of BMSc. Given the peak viable cell density (VCD) and the volume
of each bioreactor, the total number of cells was obtained. The product of the total cell
population and the specific heat of reaction provided the amount of heat generated from each
bioreactor at maximum VCD. The cooling jacket was then specified to remove the heat
generated to maintain a constant process temperature.
The overall heat transfer coefficient was approximated to be about 227 watts/m2/K based
on the typical range of 150-500 watts/m2/K for liquid-free convection with steam jackets around
a stirred tank. While bubble column reactors have free convection of liquid, their main source of
agitation comes from air bubbles passing through the column instead of a stirrer. So, the chosen
heat transfer coefficient was smaller than 500 watts/m2/K. In addition, an aspect ratio of 3:1
between the process height and diameter was used to size each bioreactor and determine the
surface area that would be in contact with the cooling jacket. A minimum difference of 10°C was
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maintained between the process temperature (TP) and the cooling jacket outlet temperature (Tco)
to ensure adequate heat transfer. Using this constraint, the coolant flow rate was interactively
changed until the coolant outlet temperature converged to the desired value. The calculated
values for cooling jacket size and energy requirements are shown in Table 9.1.
Table 9.1. Bioreactor cooling jacket fluid requirements

In addition to the coolant flow rate, an approximate power requirement was also obtained
using an estimate for an industrial cooling tower, operating in crossflow with propeller fans (SPX
Cooling, 2016). The cooling tower from SPX Cooling Technologies requires 20,000 kWh
propeller fan energy to cool 400 tons of water from 35℃ to 30℃ if constantly operated at full
capacity for 1200 hours. The cooling tower for this process can store 1.3 million pounds or 650
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US tons of water and need to cool it from 26.5℃ to 22℃. Although the amount of water varies
for both tower designs, the change in temperature is approximately the same which allows for a
rough estimate of the energy requirement for this cooling tower. The energy balance in Table 9.5
uses the energy consumption of 20,000 kW for the cooling tower.
For the chiller energy requirement, an outline provided by the Cary Company was used to
estimate the ideal chiller size and cooling capacity (Cary Company, n.d.). The chiller is assumed
to operate primarily in summer for about 122 days when the atmospheric temperature of Illinois
is higher than 25℃. Over the last decade, the maximum temperature in Illinois ranged from 34 to
41℃ (Current Results, 2021) so an average of 38℃ was used for chiller energy calculation.
Based on the outline, the chiller would need 12,200 kWh to chill water from 38℃ to 22℃ at a
rate of 408 pounds per second as included in Table 9.5.
For the scope of this project, it was encouraged to use an estimated energy requirement
for the cooling tower and the chiller rather than designing all the units. However, note that the
amount of cooling water, size of the unit, material used, etc. would significantly influence the
power requirement to run.. Therefore, a rigorous calculation of energy consumption on the
cooling tower and chiller based on fans, motors, operating capacity, and operation time should be
considered in the future.

b. Pump Requirements
Table 9.2 includes the energy consumption required for each pump to supply cooling
water to the respective bioreactors. The cast-iron centrifugal pumps are assumed to operate at a
90% efficiency with varying capacity or mass flowrate and pressure drop. The pump head was
calculated using equation 14.2 from Seider et al. and the power input was determined using a
shaft power calculation formula (Alluri, 2018).
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The cooling tower height was assumed to be similar to the full-sized bubble column
reactors, resulting in a 34.1 psig hydraulic pressure of water leaving the tower. P-102 brings that
water pressure down to 14.7 psig before it enters the chiller. P104 supplies water at a lower
pressure of 30.1 psig to the half-sized bioreactors due to their smaller process height. An
approximated distance of 300 ft was used for the pipe network connecting the chiller and the
bubble column reactors to the cooling tower. The pressure drop across the 300 ft horizontal pipe
was estimated for a circular glavanized steel pipe with 6 inch diameter and 0.004 inch surface
roughness. The estimated pressure drop of 2.4 psig gave an inlet pressure of 17.1 psig for the
remaining pumps except P-102. The hot water from the bioreactors is collected at the top of the
process height from full and half-sized bubble column reactors and sent to P-105 and P-106,
respectively, at 17.1 psig. The pressure is then reduced to 14.7 psig before entering the chiller.
The power input was determined to be the product of flowrate, pump head, water density,
gravitational constant divided by the percent efficiency.
Table 9.2. Cooling water pump energy requirements

c. Compressor Requirements
The compressors supply sterile air filtered from the plant's external environment to each
bioreactor for aerobic cell growth. The energy requirement for each compressor was based on the
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volumetric flow rate of air and the outlet pressure requirement of air supply to reach the top of
the bioreactor height. The second compressor (Comp 2 on Figure 6.1) requires about 491 kWh
to supply air to the full-sided bubble column reactors while comp 3 needs 246 kWh. Note that
the energy requirements for air supply to seed reactor 1 and 2 were significantly low due to small
sizes and were not included in the overall energy balance in Table 9.5.
Table 9.3. Air compressor energy requirements

d. Cold Room Refrigeration
In order to prevent product spoilage, all process steps downstream of the vacuum rotary
drum are carried out in a cold room. A cold room temperature of 10°F (-12°C) was selected to
keep the product cold without rendering it too hard to work with. Assuming a 15 x 10 x 10 meter
(50x30x30 ft) cold room insulated using polystyrene, an online calculator from the industrial
refrigeration company Alfa LU-VE was used to calculate the power requirements to maintain the
desired cold room temperature 24 hours per day (Alfa LU-VE, n.d.). Approximately 48 kW are
required for cooling, giving a specific cooling capacity of 32 W/m3 (see Table 9.4 for a full
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summary of cooling requirements). A full summary of the cold room specifications is listed in
Appendix E.
Table 9.4. Cold room energy requirements
Cooling Requirement

kW

Transmission Losses

12.6

Ventilation Losses

5.9

Other Heat Sources

3.1

Cooling Down

26.5

Total Required Cooling Capacity

48.1

e. Overall Energy Balance Summary
Table 9.5 summarizes the overall energy consumption for the process along with the list
of units and their quantity. The downstream process units consist of a disc stack centrifuge,
stirred tank reactor, vacuum rotary drum dryer, mixer, and screw extruders each with their own
energy requirements. The disc stack centrifuge energy requirement was based off of Alfa Laval’s
CH 900 industrial disc stack separation device at 67 kWh (“Alfa Laval CH 900,” n.d.). The
STR’s energy usage of 1.08 kWh was modeled from an online source utilizing the vessel size and
speed of agitation. Similarly, the rotary drum and mixer power requirements were formulated
upon the effective area and volume to be 5.22 kWh and 18 kWh, respectively. Lastly, the screw
extruders’ energy consumption proved to be 110 kWh each following a commercially available
product model (IDAH, n.d.).
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Table 9.5. Overall energy balance

f. Wastewater Treatment
One of the biggest concerns in this process is the amount of water required - the cell
medium is generally 5% cells by volume, which with the amount of cells produced per year
creates a yearly water demand of millions of pounds. Therefore, it is highly desirable to be able
to treat and recycle process water such that 90% can be reused after each batch, and the
remaining 10% purged. Towards that end, it was decided to allocate a wastewater treatment plant
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onsite so that after each batch, the supernatant from the disk stack centrifuges can be sent to
treatment and recycled.
After separating the used growth medium from the harvested cells, the biggest concern
for wastewater treatment is ammonia removal. Ammonia is a byproduct of cell growth that is
cytotoxic at high concentration; purging part of the recycle stream prevents its accumulation in
the system. Ammonia is also highly water soluble, requiring involved separation processes such
as reverse osmosis or treatment in bioreactors with nitrogen-removing microbes. Therefore, the
allocated wastewater treatment plant is specified to employ primary (physical screening),
secondary (biological treatment), and tertiary (specialized treatments like reverse osmosis)
treatments (Seider et al., 2017).
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Section 10: Economic Analysis

a. General Information on the Process Economics
An economic analysis of the cultured ground beef manufacturing process was conducted
using the Profitability Analysis 4.0 spreadsheet provided in section 17.8 of Seider et al., created
by Brian K. Downey (2008). The spreadsheet provides estimates and rigorous profitability
measures based on process specifications. In the following sections, the total capital investment,
production cost, cash flow, profitability, and specifications for this process will be discussed.
The cellular agriculture process located in Illinois will yield 35 million lbs of ground beef
from a manufacturing facility that would operate for 300 days a year as shown in Table 10.1.
The product will be priced at $100 per pound of ground beef to generate profit and continue the
manufacturing process. Although slaughtered ground beef price is significantly lower at $5 per
pound (US Bureau of Labor Statistics, 2022), it is reasonably comparative to the price of current
cultured meat products. According to a 2021 techno-economic analysis by the Good Food
Institute (GFI), the current production price of cultured meat ranges from $70 to $10,000 per
pound (Vergeer et al., 2021; Fassler, 2021), which is projected to reach $2.50 per pound by 2030
with large-scale production. Therefore, a set price of $100 per pound is a good starting price for
the cultured ground beef. However, the ultimate goal for this process would be to lower the
production cost by optimization and to provide a selling price that is competitive with
slaughtered ground beef.
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Table 10.1: General economic information: overall process

Table 10.2 documents an estimated chronological cycle of this process. Upon completion
of plant design by 2023 and construction by 2024, production would begin in 2025 and continue
for the next 14 years. A large portion of the total permanent investment (60%) would be
distributed for construction and the remaining amount would be distributed throughout the first
three years of production. (Further discussion of the total permanent investment is included in
Section 11.) The manufacturing plant is set to start at 80% of the design capacity by the first year
of production and take 2 years to reach 100% production capacity. A 5-year Modified
Accelerated Cost Recovery System (MACRS) is selected for this process along with a 4%
inflation rate for the product price.
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Table 10.2. Manufacturing process chronology

b. Equipment Cost Summary
Table 10.3 lists the total cost of each piece of equipment that needs to be fabricated or
purchased. It also includes the quantity that is associated with the price and the estimated bare
module factor (FBM) for each piece of equipment. The FBM was obtained from table 16.11 in
Seider, et al. for certain equipment. However, for the storage tank, FBM was not available in the
table so an estimate of 1.1 for a spherical, fixed roof storage tank was used based on published
values (Higgins et al., 2017). In addition, commercially available bubble column reactor sizes
ranged mainly from 0.01 m3 to 20 m3 which was not sufficient to reach the production goal. The
manufacturing plant requires 0.01 m3 to 300 m3 bioreactors which would occasionally undergo
high-pressure steam sterilization. Therefore, the bubble column reactors were considered as
onsite fabricated pressure vessels for cost estimation.
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Table 10.3: Equipment cost estimates
Equipment Name

Type

Quantity

Purchase
Cost

Bare Module
Factor

Bare Module
Cost

Bubble Column
Reactors

Fabricated
Equipment

7

$6,704,000

4.2

$27,887,000

Seed Reactors

Fabricated
Equipment

3

$82,000

4.2

$343,000

Rotary Drum Vacuum
Dryer

Fabricated
Equipment

1

$207,000

2.3

$481,000

Centrifugal Pumps

Process Machinery

6

$104,000

3.3

$343,200

Compressors

Process Machinery

3

$1,014,000

2.1

$2,129,000

Mixer

Process Machinery

1

$78,000

2.0

$156,000

Storage Tank

Storage

2

$234,000

1.1

$258,000

HEPA Filter

Other Equipment

3

$3,585

2.32

$8,317

Submicron Filter

Other Equipment

3

$720

2.32

$1,670

Extruder

Other Equipment

6

$1,194,000

1.4

$1,383,000

Disc Stack Centrifuge

Other Equipment

2

$1,975,000

2.0

$4,010,000

Cold Room

Other Equipment

1

$33,300

3.21

$107,000

Wastewater Treatment

Other Equipment

1

$1,115,000

3.21

$3,579,150

Total

$40,686,338

The four main types of equipment that drove up the investment cost are the bubble
column reactors, compressors, and disc stack centrifuges. The purchase cost for each full-size
(300 m3) bubble column reactor was approximately $1,200,000 and a half-size column was about
$600,000. With an FBM of 4.2, the total bare module cost of 4 full-size and 3 half-size columns
contribute $28 million to the investment. The cost may be reduced by decreasing the column size
or the number of columns required for this process. However, this would only be possible
through modification of the cell line and/or other cell growth conditions, which is discussed in
Section 14.
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The bare module cost of the cold room was estimated by surveying the manufacturing
cost of industrial cold room storage. A typical above-ground cold room storage unit costs
$33,300 to build, including HVAC system, insulation, power supply and backup (Allied
Buildings, n.d.). This estimated fabrication cost along with the bare module factor of 3.21 from
the profitability analysis spreadsheet provided a total bare module cost of $107,000 to build a
cold room onsite. In order to maintain the product at 10°F, refrigeration costs come out to $2 per
ton ($0.001/lb) of material stored as listed in Table 12.4 below (Seider et al., 2017).
The cost associated with the wastewater treatment was estimated using a purchase cost
equation for a tertiary wastewater treatment plant (Seider et al., 2017). (See Section 9 for a more
complete discussion on wastewater treatment requirements.) In order to process 25 gallons per
minute as the process requires, the bare module cost of the waste treatment plant was calculated
at approximately $3.6 million.
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Section 11: Total Permanent Investigation or Total Fixed Capital
The individual equipment cost listed in Table 10.2 is used as input in the profitability
spreadsheet to obtain the total bare module cost of about $40,700,000. Each piece of equipment
was categorized based on the description provided in Seider, et al. The bubble column reactors,
the seed reactors, and the rotary drum were characterized as “fabricated equipment” due to their
customized size requirement for large-scale production. The fabricated machinery requires
process machinery such as pumps, compressors, and mixers which could be supplied from
vendors given the standard size. The storage tanks were categorized as storage and the remaining
pieces of equipment were lumped together as “other equipment.” Although a strong effort was
made to determine the proper equipment size and quotes from vendors, the equipment
categorization is still subject to change based on new information. Table 11.1 lists the total cost
of each equipment type along with the total bare module cost.
Table 11.1. Total bare module cost summary
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Once the total bare module cost was calculated, it could be used to obtain the total
permanent investment for the process using the factors listed in Table 11.2. The percentage of
each factor specified in the table below was obtained from the profitability analysis spreadsheet
and Seider et al.
Table 11.2. Assumptions used for total permanent investment calculation

After allocating 5% of the total bare module cost to site preparation and 5% to service
facilities, the direct permanent investment (DPI) for this process was calculated to be about
$44,800,000 as shown in Table 11.3. 18% of the DPI was allocated to cover contingencies and
contractor fees and the total depreciable capital (TDC) was found to be $52,800,000. The TDC is
crucial as it accounts for a portion of maintenance costs due to equipment usage, tax, and
insurance. A 2% land cost and a 10% plant start-up cost of TDC are then added to give an
unadjusted total permanent investment (TPI) of $59,100,000. Since the plant is located in
Illinois, an investment site factor of 1.15 (Seider et al., 2017) was used to adjust the TPI and get
a final TPI of $68,000,000 for the manufacturing process.
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Table 11.3. Investment summary

Section 12: Cost of Manufacturing

a. Raw Material Cost
The cost of each raw material required to run the manufacturing process is included in
Table 12.1 below. It also includes the required ratio of raw material to ground beef on a pound
per pound basis. The product of the ratio and the cost of each raw material was calculated and

84
totaled over all the material to obtain a total weighted raw material cost of $68 per pound of
ground beef.
Table 12.1. Raw material costs

b. Byproduct Cost
Carbon dioxide is generated from aerobic cell growth in each bioreactor and is
considered the only byproduct of this process, as shown in Table 12.2. Based on the current
design, generated CO2 would be vented out of the system into the atmosphere. In the future, this
CO2 could potentially be captured in order to monetize the byproduct and reduce carbon
footprint.
Table 12.2. Byproduct costs

c. Utility Cost
The cost along with the required ratio of each utility to ground beef is summarized in
Table 12.3. The high-pressure steam, hot water, NaOH, H2SO4, and PAA are required for the
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clean-in-place (CIP) process to sterilize each unit that comes into direct contact with the product.
The cost of water in Illinois (Gregory et al., 2017) was used to estimate the cost per pound of
water supply. An overall energy requirement from Table 9.4 was used to calculate the required
ratio of electricity per pound of ground beef and the estimated cost of electricity in Illinois was
used (Electricity Local, n.d.). The utility cost per pound for the wastewater treatment and the
refrigeration at 10℉ were obtained from Table 17.1 in Seider et al. Note that hot water and
refrigeration utility costs are shown as zero but the exact values are $0.0002 and $0.001 per lb
respectively.
Table 12.3. Utility costs
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d. Fixed Cost Summary
Besides the raw material and utility costs, there is a fixed cost to run the manufacturing
facility. The fixed cost depends on several factors such as cost of labor, maintenance, operation
overhead, property tax, depletion, etc. Table 12.4 includes all the factors and the assumptions –
obtained from the profitability spreadsheet – used to calculate the total fixed cost.
Table 12.4. Factors in total fixed cost calculation
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Table 12.5 includes the summary of the cost associated with each factor and yields a total
fixed cost of $8,440,000 for this process.
Table 12.5. Fixed cost summary

88
e. Variable Cost Summary
While the fixed cost for the manufacturing process remains constant over the production
years, the cost of raw materials, utilities, and general expenses vary with the production rate of
the plant. These expenses are referred to as the variable cost which is calculated using factors
and assumptions listed in Table 12.6 and the values summarized in Table 12.7. The total variable
cost for this process was calculated to be $3 billion, almost $2 billion of which comes from the
annual raw material cost.
Table 12.6. Factors in variable cost calculation

Table 12.7. Variable cost summary
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f. Total Capital Investment
The total capital investment is estimated using the working capital calculation described
in section 17.3 by Seider et al. The working capital included funds, in addition to the fixed
capital and the startup funds, needed for the plant to run properly until payment is received from
the customer. Subtracting the accounts payable from the sum of cash reserves, accounts
receivable, and inventory yields the working capital. Table 12.8 includes the assumed period for
each factor that is needed to calculate the working capital and Table 12.9 summarizes the total
capital investment of $190 million for this process.
Table 12.8. Assumptions in working capital calculation

Table 12.9. Total capital investment summary
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Section 13: Profitability Analysis

a. Cash Flow
The cash flow for this process with MACRS depreciation for a 5-year class life, calculated over an estimated life of 17 years
including design (2023) and construction (2024) is summarized in Table 13.1. It is also graphically represented in Figure 13.1. The
cash flow is an important financial factor in understanding the profitability of the proposed manufacturing process. It is generally
referred to as the net passage of money going into and out of the company, with all of the costs as negative and after-tax profit and
depreciation as positive. Negative values in the table are enclosed with parentheses. For this process, there is no net earning during the
design and construction period. From 2025 to 2039, there are production and sales that would lead to a net positive cash flow for the
company and make the process profitable.
Table 13.1. Cash flow summary

91

Figure 13.1. Annual cash flows.
b. Return on Investment and Sensitivity Analysis
To obtain the net present value (NPV) of this project, each cash flow in Table 13.1 was
discounted to its present value using a 15% interest rate. The capital investment costs could be
recovered and the plant would have an NPV of $107,000,000 within the first year of production.
Over the 17-year lifetime of the plant, it would generate a cumulative NPV of $2 billion. In
addition, the return on investment (ROI) in the third year of production would be almost 217%,
meaning the net earning would be nearly twice the total capital investment as shown in Table
13.2.
Table 13.2. Return on investment in the third year of production
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The internal rate of return (IRR) was calculated to be 223%; it is the interest rate that would give an NPV of zero. Usually, the
profitability of alternative processes is compared using these values such that the largest IRR and the smallest NPV are desired. Table
13.3 includes a sensitivity analysis that calculates IRR based on deviations in the initial product price and the variable cost. Even at the
current variable cost of $2.8 billion, the product price could be decreased to $90/lb of ground beef and still maintain a positive IRR of
130%. This analysis is important in evaluating the profit margin for a competitive product price. As discussed in section 10, the lowest
price for cultured meat product based on GFI’s techno-economic analysis is $70 per pound. To compete in the same market, the
ground beef price of $100 per pound must decrease. For example, with a reduced price of $50 per pound, there must be a 40%
decrease in the variable cost (new variable cost of $1.7 billion) to maintain a minimum positive IRR of 72%. Since raw material
contributes to the largest share of variable cost, optimization of raw material usage may bring the cost down.
Table 13.3. Sensitivity analysis on IRR with varying price and variable cost
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Section 14: Other Important Considerations

a. Environmental Comparisons
Water pollution in traditional farming methods for cultivating beef results from nitrogen
and phosphorous runoff from farmlands into freshwater sources and the use of freshwater in
hydrating cattle. Potential water pollution in the case of cellular agriculture occurs after the cells
and media are centrifuged when process water is purged to remove any of the created ammonia.
In both cases, the effects of meat production negatively affects the surrounding water supply.
This section serves to compare the effects of both production methods to determine which results
in less water pollution in the Midwest.
Blue water usage refers to water that is used for animals drinking on a farm as well as
crop irrigation. This usage is estimated to be 112 L per kg of carcass weight in the Midwestern
region of the United States. The use of blue water for these purposes results in excreted waste in
animals which pollutes water systems via runoff. It is estimated that 24.3 grams of nitrogen
pollution is produced per kilogram of carcass weight of cattle and 0.38 milligrams of phosphorus
is polluted per kilogram of carcass weight. For 35 million pounds of cattle meat to be produced,
1.8 billion liters of blue water is required which results in 390 million pounds of nitrogen and
6,000 pounds of phosphorus entering the waterways as a pollutant (Rotz et al., 2019).
Due to the recycle of process water, only 10% of the annual requirement is purged and
emitted as waste. Therefore, of the 91 million pounds of sterile process water required
throughout all the bioreactors, only 9.1 million pounds of water is purged yearly as waste due to
its ammonia content. This equates to nearly 4.1 million liters of water, and even if the same
percentage of ammonia was produced from this usage, only 905,000 pounds of nitrogen is
released as waste. When considering the amount of water evaporated in the bioreactors, 6.4
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million pounds, then the total blue water requirement is a mere 2.9 million liters. Despite initial
concerns of the water consumption of the process, it is clear that cellular agriculture results in
decreased water pollution.
Another form of pollution in which cattle farming plays a serious role is air pollution.
Traditional cattle farming results in the formation of greenhouse gases (GHG) such as methane
and carbon dioxide (CO2). Methane production results from the hindgut fermentation that occurs
within cattle when eating plants, but this is not produced within the cell culture process, where
cells are fed pure glucose, and therefore not included in the analysis. Carbon dioxide, however, is
produced in both processes as a result of cellular respiration.
20.6 kilograms of carbon dioxide is produced for each kilogram of carcass weight
produced in traditional farming (Rotz et al., 2019). Therefore, to traditional prepare 35 million
pounds of carcass weight, then 330 million pounds of CO2 is emitted. To compare, only 17
million pounds of CO2 is emitted as a result of the industrialized production of a cultured beef
product. To conclude, the environmental harms of producing a cultured beef product as opposed
to raising cattle for slaughter are significantly reduced. These reductions are most noticeable in
the water and air pollution metrics previously mentioned. It is also important to note that there is
no soil pollution as a result of this process whereas there is clear soil pollution from farming
agriculture due to waste produced by animals on farmlands.

b. Monetary Considerations
The fossil energy consumption of traditional beef cattle production in the midwest US is
about 49MJ per kg of carcass weight (CW) (Rotz et al., 2018). The fossil fuel includes fuel,
natural gas and electricity required for cattle production. Although it is not directly comparable
to the electricity usage for the cultured ground beef plant as carcass weight includes the weight
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of bones, viscera, and other non-meat tissue, it conceptualizes the vast energy requirement for
cattle production. It takes approximately 31.5 kWh to produce one pound of traditional beef
(Save on Energy, 2019); in contrast, the ground beef product from this process requires about 7
kWh per pound, accounting for electricity and refrigeration energy requirements.

c. Ethical Considerations
The largest ethical concern for the process is the reliance on animal slaughter for two
things: fetal bovine serum, and initial harvesting of bovine muscle satellite cells. The proposed
process, while minimizing FBS wherever possible, does not manage to eliminate it entirely.
However, research is continuing in that direction; for example, a recent preprint proposed a
serum-free proliferation medium, “Beefy9,” which yielded a doubling time of 39 hours, only
slightly more than the 36.6 hours in the current process (Stout et al., 2021). The process also
assumes access to a biolab with cryogenically frozen cell starters ready to go at any time.
Currently, such a cell bank would require periodic slaughter of cattle in order to harvest more
BMSc, as natural cell lines cannot divide indefinitely. Future research into immortalizing cell
lines for cultured meat production is needed before slaughter can be eliminated from the creation
of starter cell colonies.
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d. Plant Location
The largest motivating factor in selecting the location of the plant was ready access to
raw materials. In order to feed the cells, the process consumes hundreds of millions of pounds of
corn grain and soybean hydrolysates per year. Illinois is the United States’ top producer of soy
and number 2 producer of corn (Grant, 2022), making it an attractive location for the plant.
Being in the northern part of the Midwest, Illinois also has the advantage of relatively mild
springs and summers, reducing the amount of energy needed to cool/chill the water for the
cooling jacket network.
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Section 15: Conclusion & Recommendations
Traditional beef production methods are among some of the worst environmentally costly
meat production methods currently available. The current FDA- and USDA-approved
alternatives are plant-based and do not appeal to all meat-eating consumers. The field of cellular
agriculture fills this market gap with a promise to culture meat products in vitro and minimize
animal slaughter. Though this project hoped to eliminate the need altogether, slaughter is still
required for the use of FBS to attain a viable growth density during the proliferation stages of the
upstream process, and for the initial harvesting of BMSc. The utilization of reduced FBS in
proliferation only (and none in differentiation) minimizes the amount of animal harm produced
by this process and ultimately differentiates this process from other production methods.
Nevertheless, advancements in the cell doubling time, raw material cost reduction, and further
development of a suspension BMSc line can enhance the project’s feasibility by reducing costs
and time needed to produce 35 million pounds of meat.
The slow doubling time of 36.6 hours for BMSc line influences the number of batches
produced per year and the equipment sizes. For this process, the doubling time yields 39 batches
a year to produce 35 million pounds of ground beef using 300m3 proliferation bubble column
reactors and a combination of 300m3 and 150 m3 differentiation bubble column reactors. Due to
the large size requirement, the bioreactors have to be fabricated on site, costing more that
prefabricated industrial bubble column reactors. For example, the estimated bare module cost of
a 300 m3 bubble column was about $5 million whereas a 50 m3 prefabricated reactor costs
$40,000 (“Bubble Column Reactor,” n.d.). With a lower doubling time and the same production
goal, the equipment sizes can be reduced, potentially eliminating the necessity for custom,
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on-site fabrication. If equipment sizes are kept the same, a lower doubling time can provide more
batches per year resulting in more production per facility per year.
A lower doubling time can be achieved by directed evolution using a chemostat. Directed
evolution is a common method in cell engineering that mimics the process of natural selection
towards a desired trait (Wides & Milo, 2018). A chemostat can be used to modify the dilution
rate by changing the continuous flow rate of media added to the reactor. If the dilution rate
exceeds the maximum cell growth rate, cells will be washed out of the chemostat through the
volume that is continuously removed. For this project, it is hypothesized that a chemostat could
be used with high dilution rate to induce directed evolution on the BMSc line, such that cells
with a lower growth rate would be washed out and lead to a adapted cell line with a higher
growth rate and thus lower doubling time. Further research and experiments would be required to
evaluate the feasibility of this method. If the hypothesized experiment leads to a lower doubling
time for the BMSc cell lines, it would help reduce the overall cost of this process through smaller
equipment sizes.
Another consideration for cost reduction is in raw material cost. For the process, the final
raw material cost comes out to $68 per pound of ground beef, driven up largely by the high costs
of the corn grain and soybean hydrolysates. Although it may not be possible to reduce the
amount of hydrolysates without completely changing the cell line, it may be beneficial to
allocate the enzymatic hydrolysis and hammer milling equipment onsite. The allocation of these
process units on the site would decrease the costs associated with purchasing hydrolysates. As a
result, the costs associated with the raw materials are reduced when purchasing raw corn grain
and raw soybean. However, adding more process units would increase the capital and operation
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costs of the plant, so it would be worthwhile to complete a detailed economic analysis of the
processes to determine if the costs associated far outweigh the purchase cost of hydrolysates.
Although hydrolysates significantly increases the final product cost, microcarriers
(Cytodex 1) are the biggest culprit for the high cost as it is responsible for 47.5% of the raw
material cost per pound of product. There are two potential avenues to explore regarding the
reduction of these costs: use an alternative separation method to reuse and recycle microcarriers
to reduce the amount necessary per year or engineer a suspension cell line that does not require
microcarrier usage at all.
The former allows for the process to stay virtually unchanged in all aspects except to the
addition of the STR to dissolve the dextran Cytodex I microcarriers using dextranase. It is
recommended that future research considers different solid-solid separation methods to extract
the cells from the beads without causing cell death. This research would have the potential to
improve the process financial analysis in that there may not be such a large annual usage of
Cytodex I beads. As a result, the total amount of beads and thereby, total cost associated with
them, may be reduced with this addition. However, another alternative rids the process of
microcarriers altogether.
The latter method would allow for a microcarrier free environment where cells would
grow freely in suspension. This would not only eliminate dextranase and the cost assscoiated
with replacing dissolved Cytodex 1, but also simplify the process water recycling process.
However, it is challenging to evolve an adherent cell line to a suspension cell line due to the
different growth mechanisms. HEK293 is an example of human cell line that was genetically
engineered for suspension culture, but it involved an in-depth genome engineering process
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altering gene expressions that regulated cell adhesion (Malm et al., 2020). Genetically modifying
the BMSc in a similar manner would require prolonged research and development, but the
resulting improvements to the process may be worth the investment.
Overall, if cultured beef is to become truly competitive as an alternative to traditional
slaughter meat, many improvements are required to the existing process. The current available
cell line, directly animal-derived bovine muscle satellite cells, is nowhere near as optimized as
more traditional cell culture lines such as Chinese hamster ovary or HEK293. Advancements are
needed in immortalizing the cell line to eliminate the need for slaughter for BMSc harvest,
reducing the doubling time, and potentially creating a bovine stem cell that can be easily cultured
in suspension. Further, completely eliminating slaughter from the cultured meat process requires
advancements in serum-free medium. Raw material costs also need to decrease in order to bring
down prices, especially with regards to the corn and soy hydrolysates that make up the bulk of
the cell medium. Cheaper alternatives, either in nutrient sourcing or in allocating corn and soy
processing, need to be sought in order to decrease these costs.
However, even with all of the challenges facing a potential cultured meat process
currently, the industry is still very new and quickly advancing. The current process, though
requiring a fairly expensive price point for the final product, provides a promising starting point
for cultured meat scaleup.
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Section 18: Appendices

Appendix A: Acronyms & Abbreviations
Abbreviation
BCR
BMSc
CIP
Comp

Full Term
bubble column reactor
bovine muscle satellite cell
clean-in-place
compressor

DR

differentiation reactor

DSC

disc stack centrifuge

EDTA
Ext

ethylenediaminetetraacetic acid
extruder

FBS

fetal bovine serum

FDA

Food and Drug Administration

FPR

final proliferation reactor

FSIS

Food Safety & Inspection Service

GFI

Good Food Institute

OTR

oxygen transfer rate

OUR

oxygen uptake rate

P
PAA
SR
STR
USDA
VCD

pump
peracetic acid
seed reactor
stirred tank reactor
United States Department of Agriculture
viable cell density
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Appendix B: Preliminary Versions of the PFD
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111

112
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Appendix C: Calculations

a. Material Balance
i.

Process Water and Evaporation of Process Water

114
ii.

Bioreactor Charge Requirements

iii.

Bioreactor Feed Requirements
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b. kLa requirement for Oxygen Transfer Rate and Sparge Gas Rate
To determine the mass transfer coefficient (kLa) for each bioreactor, the initial step is to
establish a relationship between oxygen transfer rate (OTR), kLa and the concentration of
dissolved oxygen in the liquid and gas phase. Modification of Fick’s first law of diffusion gives
the desired relation.
Fick’s First Law of Diffusion:
J = - Di/media * ∆𝐶𝑖/∆𝑋

(1)

Where, J = Diffusion flux
Di/media = Diffusion coefficient of species i in media
∆𝐶𝑖/∆𝑋 = concentration gradient of species i
For flux of oxygen through the air bubble, equation 1 can be modified by replacing
𝐷𝑜2/𝑚𝑒𝑑𝑖𝑎/∆𝑋 with kLaO2/media such that ∆𝑋 is considered the boundary layer thickness around the
air bubble. With this modification, the updated equation yields
(2)

𝑂𝑇𝑅 = 𝑘𝐿𝑎𝑂2 * (𝐶𝑂2/𝑔𝑎𝑠 − 𝐶𝑜2/𝑙𝑖𝑞) = 𝑘𝐿𝑎𝑂2 * (𝑃𝑂2/𝑔𝑎𝑠 − 𝑃𝑜2/𝑙𝑖𝑞) * 𝐻𝑂2/𝑚𝑒𝑑𝑖𝑎
where, 𝑃𝑂2/𝑔𝑎𝑠 and 𝑃𝑂2/𝑙𝑖𝑞 = pressure of dissolved oxygen in the gas and liquid
𝐻𝑂2/𝑚𝑒𝑑𝑖𝑎= solubility of oxygen in media

On the other hand, oxygen uptake rate (OUR) is given by the specific oxygen uptake rate
(sOUR) of a cell and the peak viable cell density (VCD) at which the cells can grow without
complication.
OUR = sOUR * VCD

(3)
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By equating OUR and OTR and isolating KLa, the desired equation for KLa requirement
is obtained as shown by equation 4.
kLaO2/media =

𝑠𝑂𝑈𝑅 * 𝑉𝐶𝐷
(𝑃𝑂2/𝑔𝑎𝑠 − 𝑃𝑜2/𝑙𝑖𝑞)*𝐻𝑂2/𝑚𝑒𝑑𝑖𝑎

(4)

Once the KLa requirement is obtained for all the bioreactors, a correlation developed by
Zedníková et al is used to obtain the gas holdup (ε𝐺) in a bubble column based on required KLa.
The gas holdup then gives the superficial velocity of the sparge gas (uG) in the reactor. Using the
cross sectional area of the bioreactor and the calculated uG one can obtain the volumentrc sparge
gas rate to meet the OTR requirements.

Figure C.1. Correlations used to the sparge gas rate calculation (Zedníková et al. 2018)
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Table C.1. Example Calculation for KLa Requirment and Sparge Gas Rate
Seed reactor 3 - KLa estimation
Values w/ 21 mol%
O2

Inputs

Units

VCD

x 10^6 cells/mL

60

Dissolved O2 set point

% sauration O2

10

p_o2/liq

mmHg O2

15.9

% O2 in sparge gas

mol % O2

21

sOUR, qo2

pmol O2/cell/hr

0.2

OUR = OTR

mmol O2/L/hr

12

H_o2/media

g O2/L/760 mmHg O2

0.033

H_o2/media

mmol O2/L/mmHg O2

0.001

O2 KLa required

1/hr

61.6

For Seed - Gas sparge rate estimate for bubble column
Inputs

Units

Values (21% O2)

O2 KLa required

1/hr

61.6

O2 KLa required

1/sec

0.017

Vessel I. D.

m

0.162

Vessel cross sectional area

m2

0.021

eps_g, Gas holdup

vol gas/vol liq

0.052

Ug, Sparge gas superficial velocity m/s

0.012

Ug, Sparge gas superficial velocity m/min

0.697

Sparge gas rate

standard L/min

14
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The carbon dioxide production for the process was calculated using mass balance and a
1:1 mole ratio between O2 and CO2 from the aerobic respiration equation. Table C.2 summarizes
the calculation for yearly CO2 production rate.
Table C.2. Summary of Yearly CO2 Production Rate
Total O2 added to process

16,613,511

lb/yr

Total O2 consumed or CO2 produced

7,670

L/min

Total O2 consumed or CO2 produced

9,443,238

lb/yr

Total NO2 in outlet

50,174

lb/yr

Total O2 left in outlet

7,170,273

lb/yr

c. Compressor Energy Requirement Calculation
Table C.3. Example Calculation for Work Required to Supply Air
Seed reactor 1 - Electric work required
Variable

Values

Unit

Density of Air at STP

1.2 kg/m3

Specific volume

0.8 m3/kg

Sparge gas rate

14.5 L/min

Sparge gas rate

0.0 m3/s

VCD
Density of cell

25000000.0 cells/mL
25.0 cells/m3

Reactor vol

0.014 m3

Working vol of bioreactor

0.010 m3

Total cells
Mass of cells
Density of water
Mass of water

0.3 cells
3.16E-11 kg
1000.0 kg/m3
10.1 kg
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Total mass in bioreactor
Total density in bioreactor

10.1 kg
750.0 kg/m3

Gravitational constant

9.8 m/s2

Bioreactor process height

0.5 m

Inlet Pressure, P1
P2 - P1
Outlet pressure, P2
Work required

d. CIP/SIP Calculation
Upstream

101325 Pa
3588 kg/m*s2
104913 Pa
0.9 J/s
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Downstream
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Appendix D: Full Clean-in-Place Specifications
Virgin Hot Water
(gal/yr)

2% NaOH
(gal/yr)

15 psig Steam
(lb/yr)

0.2% Peracetic Acid
(gal/yr)

SR 1

650

65

190

-

SR 2

1,200

120

16,000

-

SR 3

4,000

400

6,100

-

FPR 1&2, DR 1
(each)

16,000

1,600

50,000

-

DR 2-4 (each)

16,000

1,600

31,000

-

STR

6,000

600

13,000

-

DSC 1&2 (each)

16,000

1,600

-

16,000

Rotary Drum

500

50

-

500

Mixer

6,200

620

-

6,200

Ext 1-6 (each)

8,100

810

-

8,100

Storage Tanks
(each)

21,000

2,100

-

21,000
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Appendix E: Full Cold Room Refrigeration Specifications
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Appendix F: Safety Data Sheets (SDS)
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140
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145

146

147

148

149

150

151
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157

158

159

160

161
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169

170
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175

176

177

178

179

180

181

182
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186

187

188

189

190
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